Reply: Quantification of Atherosclerotic Coronary Plaque: The Missing Link Between Elevated Biochemical Markers and Adverse Outcomes in the “Vulnerable” Patient?

We greatly appreciate the comments made by Drs. Korosoglou and Katus regarding our paper [(1)][1]. The authors acknowledge the promising potential of plaque quantification for individualized prediction of acute coronary syndrome (ACS). At the same time, highly-sensitive cardiac troponin T (hsTnT)